Video Experimental Relacionado
Updated: Sep 10, 2025

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
[Vacunación contra la enfermedad pulmonar crónica]
Maria Boesing1,2, Werner Albrich3, Pierre-Olivier Bridevaux4,5
1Service de médecine et universitaire, Hôpital cantonal de Bâle-Campagne, 4410 Liestal.
Se recomienda la vacunación para pacientes con enfermedad pulmonar crónica contra la gripe, el COVID-19, el neumococo y el virus de la varicela-zoster (VZV). La mejora de las tasas de vacunación, especialmente para el neumococo, es crucial para este grupo de alto riesgo.
Área de la Ciencia:
- Pulmonología
- Enfermedades infecciosas
- Vacunas y vacunas
Más Videos Relacionados
Videos de Conceptos Relacionados
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

